MassBio is the voice of the industry on Beacon Hill. We educate policy makers about our specific needs and our significance to the economy. We also work with them to develop laws, regulations and tax policies that will foster an expansion of the life sciences super cluster in the Commonwealth.
- May 21, 2015 House Energy and Commerce Committee Unanimously Approves 21st Century Cures
- May 20, 2015 ContraFect Corporation Adds Former Cubist Executive Steven C. Gilman, PhD, to Board of Directors as Executive Chairman
- May 20, 2015 Engage and De-Risk: BioPharm America™ 2015 draws life science dealmaking ecosystem to Boston September 15–17
- May 6, 2015 State and Industry Officials Commend Eli Lilly on Plans for New Facility in Cambridge
- May 1, 2015 MassBio Launches Biomanufacturing Programming